| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/03/2006 | WO2006055503A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/03/2006 | US20060173193 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases |
| 08/03/2006 | US20060173192 Aminoalkylphenyl indolone derivatives |
| 08/03/2006 | US20060173184 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 08/03/2006 | US20060173183 Multicyclic bis-amide MMP inhibitors |
| 08/03/2006 | US20060173182 Process of preparing imatinib and imatinib prepared thereby |
| 08/03/2006 | US20060173180 Aminoalkoxyphenyl indolone derivatives |
| 08/03/2006 | US20060173061 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 08/03/2006 | US20060173059 Agent for preventing or treating portal hypertension |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173055 Pyrrole compounds useful as kinase inhibitors |
| 08/03/2006 | US20060173049 enzyme inhibitors such as 6-{2-(2-Chloro-phenyl)-5-[4-(pyrimidin-2-yloxy)-phenyl]pyrrol-1-ylmethyl}-pyridin-2-ylamine, used to treat beta-amyloid deposits and neurofibrillary tangles; Alzheimer's disease |
| 08/03/2006 | US20060173048 Imidazole derivatives |
| 08/03/2006 | US20060173046 Hydroxypyridine cgrp receptor antagonists |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173020 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 08/03/2006 | US20060173019 Heteroaryl sulfonamides and CCR2 |
| 08/03/2006 | US20060173018 Quinazolines useful as modulators of ion channels |
| 08/03/2006 | US20060173015 Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/03/2006 | US20060173012 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173008 New pyridazin-3(2h)-one derivatives |
| 08/03/2006 | US20060173004 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172994 Compounds useful as chemokine receptor antagonists |
| 08/03/2006 | US20060172989 Aminoalkoxyphenyl indolone derivatives |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060172984 Methods and compositions of novel triazine compounds |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | US20060169172 Disazo compound and ink composition containing the same |
| 08/03/2006 | DE4427056B4 Neue Carboxymethylidencycloheptimidazol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als antihypertensive und anticongestive Mittel New Carboxymethylidencycloheptimidazol derivatives, processes for their preparation and their use as antihypertensive agents and anticongestive |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2595958A1 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |
| 08/03/2006 | CA2595376A1 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 08/03/2006 | CA2594708A1 Chemical compounds |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1686120A2 Methods and compositions utilizing quinazolinones |
| 08/02/2006 | EP1685132A1 A sb 2B /sb ADENOSINE RECEPTOR ANTAGONISTS |
| 08/02/2006 | EP1685126A2 Preparation of candesartan cilexetil |
| 08/02/2006 | EP1685124A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685116A1 Quinazoline derivatives |
| 08/02/2006 | EP1685115A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 08/02/2006 | EP1685109A2 Amide compounds as ion channel ligands and uses thereof |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1684748A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 08/02/2006 | EP1529043B1 Process for the preparation of 2-methyl piperazine derivatives. |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1810807A Substituted guanidine derivatives |
| 08/02/2006 | CN1810806A Prepn process and intermediate for voriconazole |
| 08/02/2006 | CN1267431C Substituted quinazoline derivatives and their use as inhibitors |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/02/2006 | CN1267419C Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 08/01/2006 | US7084169 Aminoalkoxyindoles and methods of use |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084145 Triazole compounds useful in therapy |
| 08/01/2006 | US7084143 N-(indolecarbonyl) piperazine derivatives |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | CA2379903C Novel benzotriazoles anti-inflammatory compounds |
| 08/01/2006 | CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/27/2006 | WO2006078941A2 Novel sirtuin activating compounds and methods of use thereof |
| 07/27/2006 | WO2006078753A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | WO2006078287A2 Pde4b inhibitors and uses therefor |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006077367A1 Indoles useful in the treatment of inflamation |
| 07/27/2006 | WO2006077366A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006077365A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006058720A3 Novel compounds for the treatment of neurological disorders |
| 07/27/2006 | WO2006053555A3 Pyrazol-3-one and/or pyridazin-3-one derivatives used as inhibitors of lysyl oxidase |
| 07/27/2006 | WO2006036981A3 Small molecule modulators of cytokine activity |
| 07/27/2006 | WO2006007501A3 Mitotic kinesin inhibitors |
| 07/27/2006 | WO2005061466A9 Novel phenylalanine derivative |
| 07/27/2006 | WO2005048954A3 Continuous process for producing hydroxyazapirones by oxidation |
| 07/27/2006 | US20060167272 Intermediates for the production of polymethine compounds containing a desired counter ion with high purity and in high yields; improving the solubility in solvents, the compatibility with resins, the durability and the sensitivity to laser beams |
| 07/27/2006 | US20060167269 Compounds and methods for the inhibition of compounds cruzi |
| 07/27/2006 | US20060167262 Enantioselective sulphoxidation of 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methylthio]-1H-benzimidazole using cumene hydroperoxide in the presence of a chiral hafnium or zirconium complex; industrial scale |
| 07/27/2006 | US20060167254 Spiro 2,4-pyrimidinediamine compounds and their uses |
| 07/27/2006 | US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 07/27/2006 | US20060167236 By azo coupling, wherein the azo coupling product is subjected to a finish in an organic solvent or in an agueous organic solvent with a neutral or alkaline pH |
| 07/27/2006 | US20060167081 Ep4 receptor agonists |
| 07/27/2006 | US20060167079 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; (1E)-N-(1-{4-[2-(1-Azetidinylmethyl)-1H-imidazol-1-yl]-2-fluorophenyl}-2-oxo-3-pyrrolidinyl)-2-(5-chloro-2-thienyl)-1-propene-1-sulfonamide for example |
| 07/27/2006 | US20060167070 Triazole compounds that modulate Hsp90 activity |
| 07/27/2006 | US20060167060 pyrazolecarboxanilide derivatives such as N-(2-chloro-6-methylphenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide, used for controlling pests; effective, less costly, less toxic and environmentally friendly pesticides |
| 07/27/2006 | US20060167059 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 07/27/2006 | US20060167057 Compounds for the treatment of CNS and amyloid associated diseases |
| 07/27/2006 | US20060167056 Polymorphs of {5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl)-4-methyl-pyridin-3-ylmethyl}-ethyl-amine |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |